Uploaded October 2026 | Updated November 2026, 1 day ago
Pandemic preparedness and global health security were examined through financing gaps, vaccine production, the health workforce, access to care, and lessons from Ebola. Speakers discussed the Pandemic Fund, regional manufacturing, and faster development of vaccines, diagnostics, and treatments. They emphasized country leadership, community trust, and sustained investment to turn scientific advances into protection.
Chair
• Victor J. Dzau, Global Preparedness Monitoring Board (GPMB)
Speakers
• Javid Abdelmoneim, Médecins Sans Frontières (MSF)
• Priya Basu, The Pandemic Fund
• Teresa Graham, Roche Pharmaceuticals
• Jane Halton, Coalition for Epidemic Preparedness Innovations (CEPI)
• Jean Kaseya, Africa Centres for Disease Control and Prevention (Africa CDC)
• Georg Kippels, Federal Ministry of Health (BMG), Germany
• Frederik Kristensen, Regionalized Vaccine Manufacturing Collaborative (RVMC)
• Sharon Lewin, Doherty Institute
Explore related sessions:
• From Crisis Response to Resilience: Innovating for Health Security Beyond Borders youtube.com/live/vSvgHn8aqzI
• Designing the Surveillance Financing Landscape of the Future youtube.com/live/7pjQXvKoajI
The World Health Summit 2026 took place October 11–13 in Berlin and online, bringing together leaders and changemakers from science, politics, civil society, and the private sector to address key global health priorities.
Learn more: worldhealthsummit.org
────────────────────────
Chapters:
00:00 Introduction: Pandemic Preparedness at a Crossroads
04:25 Opening Remarks: Germany's Commitment to Pandemic Preparedness
07:50 Panel 1: Financing and Governing Global Health Security
09:00 What Has Changed Since COVID-19?
13:35 What Have Recent Disease Outbreaks Taught Us?
16:50 Africa CDC: How Can Africa Strengthen Outbreak Preparedness?
23:35 How Can Regional Vaccine Manufacturing Improve Health Security?
28:30 The Pandemic Fund: How Can Countries Build Lasting Preparedness?
34:45 What Role Does the Pharmaceutical Industry Play?
38:20 How Can African Leadership Strengthen Global Health Governance?
42:50 How Can Financing Support Sustainable Preparedness?
48:45 Panel 2: Preparedness, Equity, and Community Protection
53:00 Jane Halton: How Can the 100 Days Mission Accelerate Pandemic Response?
60:00 What Research Is Needed for Future Vaccines and Therapeutics?
65:45 What Are the Challenges of Responding to Ebola in Conflict Settings?
71:50 How Can Clinical Trials Be Financed and Prepared in Advance?
77:00 How Can Research Partnerships Accelerate Therapeutic Development?
80:30 How Can Frontline Health Workers Be Better Protected?
84:00 How Should We Measure Pandemic Readiness?
86:30 Why Are Community Trust and Engagement Essential?
88:00 Closing Reflections: What Must Change Before the Next Pandemic?
Pandemic preparedness and global health security were examined through financing gaps, vaccine production, the health workforce, access to care, and lessons from Ebola. Speakers discussed the Pandemic Fund, regional manufacturing, and faster development of vaccines, diagnostics, and treatments. They emphasized country leadership, community trust, and sustained investment to turn scientific advances into protection.
Chair
• Victor J. Dzau, Global Preparedness Monitoring Board (GPMB)
Speakers
• Javid Abdelmoneim, Médecins Sans Frontières (MSF)
• Priya Basu, The Pandemic Fund
• Teresa Graham, Roche Pharmaceuticals
• Jane Halton, Coalition for Epidemic Preparedness Innovations (CEPI)
• Jean Kaseya, Africa Centres for Disease Control and Prevention (Africa CDC)
• Georg Kippels, Federal Ministry of Health (BMG), Germany
• Frederik Kristensen, Regionalized Vaccine Manufacturing Collaborative (RVMC)
• Sharon Lewin, Doherty Institute
Explore related sessions:
• From Crisis Response to Resilience: Innovating for Health Security Beyond Borders youtube.com/live/vSvgHn8aqzI
• Designing the Surveillance Financing Landscape of the Future youtube.com/live/7pjQXvKoajI
The World Health Summit 2026 took place October 11–13 in Berlin and online, bringing together leaders and changemakers from science, politics, civil society, and the private sector to address key global health priorities.
Learn more: worldhealthsummit.org
────────────────────────
Chapters:
00:00 Introduction: Pandemic Preparedness at a Crossroads
04:25 Opening Remarks: Germany's Commitment to Pandemic Preparedness
07:50 Panel 1: Financing and Governing Global Health Security
09:00 What Has Changed Since COVID-19?
13:35 What Have Recent Disease Outbreaks Taught Us?
16:50 Africa CDC: How Can Africa Strengthen Outbreak Preparedness?
23:35 How Can Regional Vaccine Manufacturing Improve Health Security?
28:30 The Pandemic Fund: How Can Countries Build Lasting Preparedness?
34:45 What Role Does the Pharmaceutical Industry Play?
38:20 How Can African Leadership Strengthen Global Health Governance?
42:50 How Can Financing Support Sustainable Preparedness?
48:45 Panel 2: Preparedness, Equity, and Community Protection
53:00 Jane Halton: How Can the 100 Days Mission Accelerate Pandemic Response?
60:00 What Research Is Needed for Future Vaccines and Therapeutics?
65:45 What Are the Challenges of Responding to Ebola in Conflict Settings?
71:50 How Can Clinical Trials Be Financed and Prepared in Advance?
77:00 How Can Research Partnerships Accelerate Therapeutic Development?
80:30 How Can Frontline Health Workers Be Better Protected?
84:00 How Should We Measure Pandemic Readiness?
86:30 Why Are Community Trust and Engagement Essential?
88:00 Closing Reflections: What Must Change Before the Next Pandemic?










